SENEGAL Work Plan FY 2017 Project Year 6
Total Page:16
File Type:pdf, Size:1020Kb
SENEGAL Work Plan FY 2017 Project Year 6 October 2016‒September 2017 ENVISION is a global project led by RTI International in partnership with CBM International, The Carter Center, Fred Hollows Foundation, Helen Keller International, IMA World Health, Light for the World, Sightsavers, and World Vision. ENVISION is funded by the US Agency for International Development under cooperative agreement No. AID-OAA-A-11-00048. The period of performance for ENVISION is September 30, 2011 through September 30, 2019. The author’s views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government. ENVISION PROJECT OVERVIEW The U.S. Agency for International Development (USAID)’s ENVISION project (2011‒2019) is designed to support the vision of the World Health Organization (WHO) and its member states by targeting the control and elimination of seven neglected tropical diseases (NTDs), including lymphatic filariasis (LF), onchocerciasis (OV), schistosomiasis (SCH), three soil-transmitted helminths (STH; roundworm, whipworm, and hookworm), and trachoma. ENVISION’s goal is to strengthen NTD programming at the global and country levels and support Ministries of Health (MOHs) to achieve their NTD control and elimination goals. At the global level, ENVISION—in close coordination and collaboration with WHO, USAID, and other stakeholders—contributes to several technical areas in support of global NTD control and elimination goals, including the following: • drug and diagnostics procurement where global donation programs are unavailable • capacity strengthening • management and implementation of ENVISION’s Technical Assistance Facility (TAF) • disease mapping • NTD policy and technical guideline development • NTD monitoring and evaluation (M&E). At the country level, ENVISION provides support to national NTD programs by contributing strategic technical and financial assistance for a comprehensive package of NTD interventions, including the following: • strategic annual and multi-year planning • advocacy • social mobilization and health education • capacity strengthening • baseline disease mapping • preventive chemotherapy (PC) or mass drug administration (MDA) • drug and commodity supply management and procurement • program supervision • M&E, including disease-specific assessments (DSAs) and surveillance. In Senegal, ENVISION project activities are implemented by RTI International. ENVISION FY17 PY6 Senegal Work Plan i TABLE OF CONTENTS Page ENVISION Project Overview ........................................................................................................................... i List of Tables ................................................................................................................................................. ii Acronyms List ............................................................................................................................................... iii Planned Activities .......................................................................................................................................... 6 1) NTD Program Capacity Strengthening .............................................................................................. 6 a) Strategic Capacity Strengthening Approach ................................................................................. 6 b) Capacity Strengthening Interventions .......................................................................................... 7 c) Monitoring Capacity Strengthening .............................................................................................. 7 2) Project Assistance ............................................................................................................................. 7 a) Strategic Planning ......................................................................................................................... 7 b) NTD Secretariat ............................................................................................................................. 9 c) Advocacy ....................................................................................................................................... 9 d) Social Mobilization ........................................................................................................................ 9 e) Training ....................................................................................................................................... 15 f) Mass Drug Administration .......................................................................................................... 16 g) Drug and Commodity Supply Management and Procurement .................................................. 17 h) Supervision .................................................................................................................................. 17 i) M&E ............................................................................................................................................ 19 3) Maps................................................................................................................................................ 22 Appendix 1. SUMMARY OF ACTIVITIES ....................................................................................................... 28 Appendix 2. Table of USAID-supported Regions and Districts .................................................................... 30 LIST OF TABLES Table 1. Social mobilization/communication activities and materials checklist ........................................ 12 Table 2. USAID-supported coverage results for FY16 and targets for FY17 ............................................... 16 Table 3. Planned disease-specific assessments (DSAs) for FY17 by disease ............................................... 21 ENVISION FY17 PY6 Senegal Work Plan ii ACRONYMS LIST AE Adverse Event AFRO Africa Regional Office (WHO) ALB Albendazole APOC African Programme for Onchocerciasis Control (WHO) ARG Africa Resource Group ASTMH American Society of Tropical Medicine & Hygiene BREIPS Bureaux Régionaux de l’Éducation et de l’Information pour la Santé (Regional Offices for Health Education and Information) CCA Circulating Cathodic Antigen CDC United States Centers for Disease Control and Prevention CDD Community Drug Distributor CDTI Community-Directed Treatment with Ivermectin CM Case Management CODEC Collectifs des Directeurs d’École (School Principals’ Group) COR-NTD Coalition for Operational Research on NTDs CRS Catholic Relief Services CSR Corporate Social Responsibility CY Calendar Year DBS Dried Blood Spot DCMS Division du Contrôle Médical Scolaire (School Health Control Division) (MEN) DLM Direction de la Lutte contre la Maladie (Disease Control Directorate) (MSAS) DNA Deoxyribonucleic Acid DQA Data Quality Assessment DSA Disease-Specific Assessment ECD Équipe Cadre de District (Health District Management Team) ECR Équipe Cadre de Région (Health Region Management Team) ELISA Enzyme-Linked Immunosorbent Assay ENDA Santé Environnement et le Développement en Afrique-Santé (Environment and Development in Africa-Health) EPIRF Epidemioogical Data Reporting Form FARA Fixed Amount Reimbursement Agreement (USAID) FTS Filariasis Test Strip FY Fiscal Year Groupe ISSA Groupe Innovation et Système de Santé en Afrique (Innovation Group and Health System in Africa) GTMP Global Trachoma Mapping Project HQ Headquarters HRA High-Risk Adult HSS+ Health Systems Strengthening Plus (USAID) IA Inspection d’Académie (Schools Inspectorate) ICP Infirmier Chef de Poste (Health Post Head Nurse) ICT card Immunochromatographic Test Card IE Inspection de l’Éducation (Education Inspectorate) IEC Information, Education, and Communication ENVISION FY17 PY6 Senegal Work Plan iii IEF Inspection de Formation et de l’Education (Training and Education Inspectorate) IME Inspection Médicale des Étudiants (Medical Inspectorate of Students) IR Intermediate Result IST Inter-Country Support Team (WHO/AFRO) IT Information Technology ITI International Trachoma Initiative IVM Ivermectin JRF Joint Reporting Form (WHO) JRSM Joint Request for Selected PC Medicines (WHO) LF Lymphatic Filariasis LOE Level of Effort M&E Monitoring and Evaluation MCD Médecin-Chef de District (Health District Head Doctor) MCR Médecin-Chef de Région (Health Region Head Doctor) MDA Mass Drug Administration MDP Mectizan® Donation Program MEB Mebendazole MEN Ministère de l’Education National (Ministry of National Education) Mf Microfilaraemia MHA Ministère de l’Hydraulique et de l’Assainissement (Ministry of Water and Sanitation) MOH Ministry of Health MSAS Ministère de la Santè et de l’Action Sociale (Ministry of Health and Social Work) MSH Management Sciences for Health NGO Nongovernmental Organization NTD Neglected Tropical Disease OMVS Organisation pour la Mise en Valeur du Fleuve Sénégal (Senegal River Development Organization) OV Onchocerciasis PC Preventive Chemotherapy PCR Polymerase Chain Reaction PEPAM Programme d’Eau Potable et d’Assainissement du Millénaire (Millennium Potable Water and Sanitation Program) (MHA) PGIRE Projet de Gestion Intégrée des Ressources en Eau et de Développement des Usages Multiples du Bassin du Fleuve Sénégal (Integrated Water Resource Management Project) (OMVS) PNA Pharmacie Nationale d’Approvisionnement (National Supply Pharmacy) PNEFL Programme National d’Élimination de la Filariose Lymphatique (National Lymphatic